Skip to Content

Ortho Clinical Diagnostics Holdings plc

Merger

  • Date:
  • 12/23/2021
  • Company Name:
  • Ortho Clinical Diagnostics Holdings plc
  • Stock Symbol:
  • OCDX
  • Company Name - Buyer:
  • Quidel Corporation
  • Stock Symbol - Buyer:
  • QDEL
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 12/23/2021

Case Finder

Locate any case using the tools below.

NEW YORK, December 23, 2021 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Ortho Clinical Diagnostics Holdings plc (NASDAQ: OCDX) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Quidel Corporation (NASDAQ: QDEL).

On December 23, 2021, Ortho announced that it had entered into an agreement to be acquired by Quidel in a deal valued at approximately $6 billion.  Pursuant to the merger agreement, Ortho stockholders will receive $7.14 in cash and 0.1055 shares of Quidel common stock for each share of Ortho common stock owned.  The deal is scheduled to close in the first half of 2022.

Bragar Eagel & Squire is concerned that Ortho’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement.  Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Ortho’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Ortho Clinical Diagnostics Holdings plc. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: